# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-030057
Filing Date
2019-08-07
Accepted
2019-08-07 16:08:44
Documents
84
Period of Report
2019-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | dvax-10q_20190630.htm iXBRL | 10-Q | 2663051
2 | EX-10.1 | dvax-ex101_35.htm | EX-10.1 | 219387
3 | EX-10.2 | dvax-ex102_36.htm | EX-10.2 | 77376
4 | EX-10.3 | dvax-ex103_249.htm | EX-10.3 | 13740
5 | EX-10.4 | dvax-ex104_250.htm | EX-10.4 | 17285
6 | EX-31.1 | dvax-ex311_9.htm | EX-31.1 | 17835
7 | EX-31.2 | dvax-ex312_11.htm | EX-31.2 | 17837
8 | EX-31.3 | dvax-ex313_6.htm | EX-31.3 | 17780
9 | EX-32.1 | dvax-ex321_8.htm | EX-32.1 | 6110
10 | EX-32.2 | dvax-ex322_10.htm | EX-32.2 | 6113
11 | EX-32.3 | dvax-ex323_7.htm | EX-32.3 | 6331
12 | GRAPHIC | gic2pboc1blg000001.jpg | GRAPHIC | 21793
13 | GRAPHIC | gmqs0mvivmgp000001.jpg | GRAPHIC | 21793
| Complete submission text file | 0001564590-19-030057.txt |  | 9698191

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
14 | XBRL TAXONOMY EXTENSION SCHEMA | dvax-20190630.xsd | EX-101.SCH | 56741
15 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | dvax-20190630_cal.xml | EX-101.CAL | 55724
16 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | dvax-20190630_def.xml | EX-101.DEF | 223674
17 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | dvax-20190630_lab.xml | EX-101.LAB | 472368
18 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | dvax-20190630_pre.xml | EX-101.PRE | 378387
19 | EXTRACTED XBRL INSTANCE DOCUMENT | dvax-10q_20190630_htm.xml | XML | 1766886

Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34207 | Film No.: 191005524
SIC: 2834 Pharmaceutical Preparations